Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Journal of Lipid Mediators and Cell Signalling
|
March 1, 1994
Evidence for a role of platelet activating factor in hypovolemic shock in the rat
B Zingarelli, F Squadrito, F Bussolino, et al.
Pharmacological Research
|
March 1, 1996
Endotoxin tolerance impairs a pertussis-toxin-sensitive G-protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats
D Altavilla, F Squadrito, P Canale, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1994
Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats
M Ioculano, F Squadrito, D Altavilla, et al.
Pharmacology
|
December 1, 1994
Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock
P Canale, F Squadrito, D Altavilla, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidation
G M Campo, F Squadrito, D Altavilla, et al.
European Journal of Pharmacology
|
November 3, 1995
G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis
D Altavilla, F Squadrito, P Canale, et al.
British Journal of Pharmacology
|
December 1, 1994
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock
F Squadrito, D Altavilla, P Canale, et al.
Cancer Research
|
August 18, 2018
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8<sup>+</sup> T Cells-Response
Fernando P Canale, María C Ramello, Nicolás Núñez, et al.
Agents and Actions
|
July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury
F Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology
|
September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats
F Squadrito, M Ioculano, D Altavilla, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Journal of Lipid Mediators and Cell Signalling
|
March 1, 1994
Evidence for a role of platelet activating factor in hypovolemic shock in the rat
B Zingarelli, F Squadrito, F Bussolino, et al.
Pharmacological Research
|
March 1, 1996
Endotoxin tolerance impairs a pertussis-toxin-sensitive G-protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats
D Altavilla, F Squadrito, P Canale, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1994
Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats
M Ioculano, F Squadrito, D Altavilla, et al.
Pharmacology
|
December 1, 1994
Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock
P Canale, F Squadrito, D Altavilla, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidation
G M Campo, F Squadrito, D Altavilla, et al.
European Journal of Pharmacology
|
November 3, 1995
G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis
D Altavilla, F Squadrito, P Canale, et al.
British Journal of Pharmacology
|
December 1, 1994
Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock
F Squadrito, D Altavilla, P Canale, et al.
Cancer Research
|
August 18, 2018
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8<sup>+</sup> T Cells-Response
Fernando P Canale, María C Ramello, Nicolás Núñez, et al.
Agents and Actions
|
July 1, 1993
Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury
F Squadrito, M Ioculano, D Altavilla, et al.
Pharmacology
|
September 1, 1993
G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats
F Squadrito, M Ioculano, D Altavilla, et al.
Page
of 6